Clinical Trial Update: Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing tacrolimus/sirolimus/methotrexate to tacrolimus/methotrexate or cyclosporine/mycophenolate mofetil for GVHD prophylaxis after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• METHOTREXATE (METHOTREXATE)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Non-hodgkin Lymphoma, Hodgkin Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2015-12-18